论文部分内容阅读
Background It remains unclear what the antiviral therapy affects disease-free survival (DFS) and overall survival (OS)of patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) at different tumor stages and baselineHBV DNA levels. In